-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IVWTZ/DRURzmoXEu6SrGZbDfstnaBRQXVs1mo4GT0otiE4/NNXCh9tUxDXhKNuKS LGbBnp5dQ0Y6zWB/3Wt0YQ== 0001209191-07-000394.txt : 20070103 0001209191-07-000394.hdr.sgml : 20070101 20070103133402 ACCESSION NUMBER: 0001209191-07-000394 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061229 FILED AS OF DATE: 20070103 DATE AS OF CHANGE: 20070103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THIER SAMUEL O MD CENTRAL INDEX KEY: 0001144773 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03305 FILM NUMBER: 07502970 BUSINESS ADDRESS: BUSINESS PHONE: 9786586000 MAIL ADDRESS: STREET 1: C/O CHARLES RIVER LABORATORIES STREET 2: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERCK & CO INC CENTRAL INDEX KEY: 0000064978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221109110 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MERCK DR STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 9084231688 MAIL ADDRESS: STREET 1: ONE MERCK DR STREET 2: PO BOX 100 WS3AB-05 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2006-12-29 0 0000064978 MERCK & CO INC (MRK) 0001144773 THIER SAMUEL O MD MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT ST., BULFINCH 370 BOSTON MA 02114-2606 1 0 0 0 Common Stock 20 D Phantom Stock 2006-12-29 4 A 0 997.7064 43.60 A Common Stock 997.7064 20171.4724 D 1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. Debra A. Bollwage as Attorney-in-Fact for Samuel O. Thier 2007-01-03 -----END PRIVACY-ENHANCED MESSAGE-----